FDA compounding review On December 4, 2024, the FDA Pharmacy Compounding Advisory Committee (PCAC) reviewed AOD-9604 (free base) and AOD-9604 acetate against the 503A Bulks List
Oral is unproven and likely less effective
Beyond that, using the thinnest needle that works for your situation, injecting slowly, and never forcing medication into tissue that feels resistant all protect long-term tissue health
However, MitoQ failed to reduce DPI-induced cell death at all tested time points ( Figure 1C )
At our White Plains clinic, we offer offers treatments like vitamin IV drips, tri-immune boost shots, NAD+, peptides, glutathione, lipotropics, and B vitamin shots that help support your bodys natural recovery, improve mental clarity and focus, and help you function at a higher level no matter where you are starting from